Isabelle Vergely
University of Paris
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Isabelle Vergely.
FEBS Letters | 1991
Michel Wakselman; Roger Joyeau; Randa Kobaiter; N. Boggetto; Isabelle Vergely; Jean Maillard; Veronica Okochi; Jean-Jacques Montagne; Michèle Reboud-Ravaux
A functionalized N‐aryl azetidinone has been shown to inactive human leukocyte elastase (HLE) and porcine pancreatic elastase (PPE) by an enzyme‐mediated process. The inactivation is characterized by the following kinetic constants at pH 8.0 and 37°C: k max=0.035 s−1, K 1=1.2 × 10 −4 M for HLE, 0.08 s−1 and 2.7 × 10−4 M for PPE, respectively. Two parent molecules devoid of the latent leaving group failed to inactive HLE and PPE and behaved as substrates of these enzymes. A suicide mechanism involving the formation of an acyl‐enzyme and the simultaneous unmasking of a latent quinonimmonium methide ion which irreversibly reacts with an active site nucleophile. Moreover, the inhibitor is still effective at inhibiting elastase preabsorbed onto elastin.
European Journal of Medicinal Chemistry | 1995
Isabelle Vergely; N. Boggetto; Veronica Okochi; S Golpayegani; Michèle Reboud-Ravaux; Randa Kobaiter; Roger Joyeau; Michel Wakselman
Summary A series of functionalized N -aryl azetidin-2-ones with a latent alkylating group was prepared by a flexible four-step synthesis. They met criteria expected for a suicide-type inactivation of human leukocyte elastase (HLE) and porcine pancreatic elastase (PPE), with no inactivation of trypsin- and chymotrypsin-like proteases. The inhibition potency was dependent on the halogen substituents at C-3 (F, F; Cl, Cl; Br, Br) and the nature and the position relative to nitrogen of the latent benzylic leaving group (F, Cl, Br). Better inactivations of HLE compared with PPE were observed with azetidinones gem -disubstituted by Cl and Br rather than by F. Their protio analogs, which are devoid of the latent quinoniminium methide electrophile, behave as simple substrates of elastases.
Bioorganic & Medicinal Chemistry | 1997
Driss Qasmi; Eve de Rosny; Loïc René; Bernard Badet; Isabelle Vergely; N. Boggetto; Michèle Reboud-Ravaux
A series of novel synthetic peptides containing an N-terminal glyoxylyl function (CHOCO-) have been tested as inhibitors of HIV-1 protease. The N-glyoxylyl peptide CHOCO-Pro-Ile-Val-NH2, which fulfills the specificity requirements of the MA/CA protease cleavage site together with the criteria of transition state analogue of the catalyzed reaction, was found to be a moderate competitive inhibitor although favorable interactions were visualized between its hydrated form and the catalytic aspartates using molecular modeling. Increasing the length of the peptide sequence led to compounds acting only as substrates.
Tetrahedron-asymmetry | 1997
C. Doucet; Isabelle Vergely; Michèle Reboud-Ravaux; Jean Guilhem; Randa Kobaiter; Roger Joyeau; Michel Wakselman
Abstract (3R)- and (3S)-N-(2-chloromethylphenyl)-3-bromo-3-fluoroazetidin-2-ones 2 were synthesized via the separation of diastereoisomeric phenylglycinol derivatives of the starting 2,3-dibromo-2-fluoropropanoic acid. Acidic hydrolysis of the hydroxyamides led to the chiral trihalogenopropanoic acids. Then, an expeditious four step synthesis provided the (3S)- and (3R)-azetidinones 2, both of which behaved as strictly irreversible inhibitors of HLE. The configuration of the bromofluorocarbon was shown to have a significant effect on the partition ratio: kcat/kinact=4.6 and 34.3 for (3S)- and 3R)-2, respectively.
Biochimica et Biophysica Acta | 1991
Anne-Cécile Vilain; Veronica Okochi; Isabelle Vergely; Michèle Reboud-Ravaux; Jean-Paul Mazaleyrat; Michel Wakselman
3-Benzyl-6-chloromethyl-3,4-dihydrocoumarin inhibits human leucocyte elastase (HLE) and porcine pancreatic elastase (PPE) through a mechanism-based process characterized by the following apparent enzyme-inhibitor dissociation constants, Ki, and limiting inactivation rate constants k2: 200 microM (HLE), 69 microM (PPE) and 5.10(-2) s-1 (HLE), 17.7.10(-2) s-1 (PPE) at pH 8.0, 37 degrees C. Bis(4-acyloxyphenyl)methane derivatives with a benzylic halogen as potential leaving group have also been synthesized and studied. They transiently inactivate PPE and HLE through the formation of an acyl-enzyme.
Clinica Chimica Acta | 1992
Jean-Louis Maillard; Catherine Favreau; Isabelle Vergely; Michèle Reboud-Ravaux; Roger Joyeau; Randa Kobaiter; Michel Wakselman
N-(2-chloromethylphenyl) 3,3-difluoroazetidin-2-one (AA 231-1), a specific suicide-type inhibitor of elastase which is known to suppress the lysis of chromogenic oligopeptides, elastin and elastic fibers, is effective also in preventing the degradation of the vascular basement membrane. The degradation of porcine glomerular basement membrane by purified human leukocyte elastase (HLE), was reduced in proportion of inhibitor dose (8.3 microM for 50% inhibition). It is noteworthy that there was no reduction of the inhibitory effect when the addition of AA 231-1 was delayed for 1 h after the addition of the enzyme to the substrate. In the guinea pig, reduction of the dermal microhemorrhage due to HLE was related to the dose of inhibitor and to its preincubation time with HLE before intradermal injection. The inflammatory hemorrhage associated with the Arthus skin reaction was moderately depressed by AA 231-1 in situ. A part of the vascular permeability induced by HLE also responded to the inhibitor. In spite of the tissular diffusion and the time-dependence parameters which restrict responsiveness of elastase to AA 231-1 in vivo this biochemical compound should be helpful in the study and possibly the cure of vascular injury related to elastase.
Journal of Pharmacy and Pharmacology | 1996
R. Joyeau; A. Felk; S. Guilaume; M. Wakselman; Isabelle Vergely; C. Doucet; N. Boggetto; Michèle Reboud-Ravaux
N‐aryl‐3,3‐difluoroazetidin‐2‐ones featured by a latent electrophilic methylene quinoniminium function have been synthesized and evaluated as inhibitors of human leucocyte elastase.
Journal of Pharmacy and Pharmacology | 1993
Anne-Cécile Vilain; Bernard Pirotte; Isabelle Vergely; N. Boggetto; Bernard Masereel; M. Schynts; Jacques Delarge; Michèle Reboud-Ravaux
Abstract— Twenty new derivatives of 4‐amino‐4H‐1,2,4‐triazole and 5‐aminothiazole have been examined for their inhibitory potential towards serine and aspartic proteases. Upon prolonged incubation with enzyme, the phenylacetylaminothiazolium salts exhibit progressive, time‐dependent inhibition of chymotrypsin according to a first‐order process. The formation of a tetrahedral transition state‐like complex by attack of the active‐site serine at the C2‐position of the pseudobase form of the thiazolium may be responsible for the observed effect. Triazolium salts appeared to be simple competitive inhibitors of this enzyme, effective in the Mm range concentration. Poor inhibitions of trypsin and pepsin were also obtained in the triazolium series. In spite of their structural analogy with β‐lactams, the selected derivatives failed to inhibit human leucocyte elastase.
Journal de pharmacie de Belgique | 1996
Michèle Reboud-Ravaux; N. Boggetto; C. E. Doucet; E. H. De Rosny; Isabelle Vergely; N. M. Thierry; Augustin Amour
Pharmaceutisch weekblad | 1992
M. Schynts; N. Boggetto; B. Masereel; Bernard Pirotte; S. Fesquet; Isabelle Vergely; J. Delarge; M. Reboud-Ravaux